FMC Corporation (FMC) Earnings Call Transcripts
FMC Corporation's Latest Earnings Call - June 17, 2026
In the second quarter of fiscal year 2026, FMC Corporation reported strong performance, with management confirming guidance for the quarter and expressing confidence in the full year outlook. Revenue and earnings figures were not disclosed, but management indicated that the second half of the year is expected to be robust, particularly in Latin America. Notably, FMC signed a $200 million licensing agreement with Corteva for a new AI molecule, which will aid in their debt reduction strategy aimed at a $1 billion target.
Reported metrics
| Metric | Value |
|---|---|
| Revenue | |
| Earnings | |
| Debt Reduction Target | $1 billion (positive) |
| Order Book in Brazil | Double last year (positive) |
| Isoflex Revenue Potential | $300 million (positive) |
| Free Cash Flow | Neutral (neutral) |
Guidance from management
Management confirmed guidance for Q2 and expressed confidence in meeting full-year targets, particularly due to strong order books in Latin America.
What management said
You know what France is going to have a third star. I'm certain of it. And I was hesitating, but I thought it would not be appropriate out of respect for this group here, but I was about to wear French Jersey today, but I decided not to do it. But it was worrying one yesterday.
What analysts pressed on
Analysts raised concerns about the competitive pressures on Rynaxypyr and the potential impact on pricing and market share. There is also apprehension regarding the company's ability to manage free cash flow amidst restructuring costs.
Main topics on the call
- AI Molecule Licensing Agreement — FMC announced a $200 million licensing deal with Corteva for a new AI molecule, which is expected to enhance their market reach and support debt reduction efforts. CEO Pierre Brondeau stated, "the benefit of this deal is...
- Debt Reduction Progress — Management indicated they are halfway to their goal of $1 billion in debt reduction, with the licensing deal and previous asset sales contributing significantly. Brondeau noted, "we are at half of the way -- we're at hal...
- Full Year Guidance — FMC maintained its full-year guidance, with management expressing confidence in achieving targets based on strong order books, particularly in Brazil. Brondeau mentioned, "I don't see any reason to change the full year."
- Market Conditions in Latin America — Management highlighted improved market conditions in Brazil compared to the previous year, with expectations of significantly higher orders. Brondeau stated, "we have a much healthier situation around Brazil and Latin Am...
Read the full FMC Corporation transcript (June 17, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About FMC Corporation
FMC Corporation (FMC) is a publicly listed company in the Chemicals industry, within the Materials sector. It trades on NYSE and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 75 calls on record spanning February 6, 2020 to July 30, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 75 FMC Corporation earnings call transcripts on record, spanning February 6, 2020 to July 30, 2026. Based on this history, FMC Corporation reports quarterly. The most recent call on file is dated July 30, 2026. The full list is below — each row opens the complete, free-to-read transcript.